YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2014	Child-Pugh Score Is an Independent Risk Factor for Immediate Bleeding after Colonoscopic Polypectomy in Liver Cirrhosis	YONSEI MEDICAL JOURNAL
2014	우리나라 만성콩팥병으로 인한 사회경제적 부담 추정에 관한 연구	Korean Public Health Research (대한보건연구)
2014	ESD 전후 병리 진단의 차이, 문제점과 대책	Korean Clinical Digestive Endoscopy (대한임상소화기내시경)
2014	The Combination of Vitamin D Deficiency and Mild to Moderate Chronic Kidney Disease Is Associated With Low Bone Mineral Density and Deteriorated Femoral Microarchitecture: Results From the KNHANES 2008–2011	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2014	Early-stage chronic kidney disease, insulin resistance, and osteoporosis as risk factors of sarcopenia in aged population: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2008–2009	OSTEOPOROSIS INTERNATIONAL
2014	Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular Carcinoma	YONSEI MEDICAL JOURNAL
2014	Serum 25-Hydroxyvitamin D and Insulin Resistance in Apparently Healthy Adolescents	PLOS ONE
2014	Role of miRNAs in bone and their potential as therapeutic targets	CURRENT OPINION IN PHARMACOLOGY
2014	Combination of a peroxisome proliferatoractivated receptor-gamma agonist and an angiotensin II receptor blocker attenuates myocardial fibrosis and dysfunction in type 2 diabetic rats	JOURNAL OF DIABETES INVESTIGATION
2014	Increased Dialysate MCP-1 is Associated with Cardiovascular Mortality in Peritoneal Dialysis Patients: A Prospective Observational Study	AMERICAN JOURNAL OF NEPHROLOGY
2014	A phase II trial of Cremorphor EL-free paclitaxel (Genexol-PM) and gemcitabine in patients with advanced non-small cell lung cancer	CANCER CHEMOTHERAPY AND PHARMACOLOGY
2014	Late Gadolinium Enhancement in Cardiac MRI in Patients with Severe Aortic Stenosis and Preserved Left Ventricular Systolic Function Is Related to Attenuated Improvement of Left Ventricular Geometry and Filling Pressure after Aortic Valve Replacement	KOREAN CIRCULATION JOURNAL
2014	Clinical significance of Ki-67 and p53 expression in curatively resected non-small cell lung cancer	TUMOR BIOLOGY
2014	Autophagy Activity in Pulmonary Metastatic Tumor Tissues from Colorectal Cancer: A Pilot Study	YONSEI MEDICAL JOURNAL
2014	Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.	HEPATOLOGY
2014	Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitis.	WORLD JOURNAL OF GASTROENTEROLOGY
2014	2014 Korean guidelines for appropriate utilization of cardiovascular magnetic resonance imaging: a joint report of the Korean Society of Cardiology and the Korean Society of Radiology.	KOREAN JOURNAL OF RADIOLOGY
2014	Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease.	EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
2014	패혈쇼크의 임상 양상으로 발현된 전신 모세혈관누출 증후군 1예	Korean Journal of Medicine
2014	Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial.	LANCET ONCOLOGY